MET-233I
A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
Pfizer · Phase 1/2 · Completed · Enrollment 201
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Part A Cohort | Obesity or overweight | n/r | 4 | n/r | n/r |
| Part B Cohort | Obesity or overweight | n/r | 4 | n/r | n/r |
| Part C Cohort | Obesity or overweight | n/r | 4 | n/r | n/r |
| Part D Cohort | Obesity or overweight | n/r | 4 | n/r | n/r |
| Part E Cohort | Obesity or overweight | n/r | 4 | n/r | n/r |
| Part G Cohort | Obesity or overweight | n/r | 4 | n/r | n/r |